Clinical Trial Update: Safety and Tolerability of Inhaled Treprostinil in Adult PH Due to COPD [Phase 2]

View source ↗

Summary

A Phase 2 trial of inhaled treprostinil for adult pulmonary hypertension due to chronic obstructive pulmonary disease has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Obstructive Pulmonary Disease
• Pulmonary Hypertension

Drugs mentioned

• Treprostinil (inhaled) (treprostinil)

Snippet

Sponsor: United Therapeutics | Conditions: Pulmonary Hypertension, Chronic Obstructive Pulmonary Disease | Phase 2 | Status: WITHDRAWN